Skip to main content
. Author manuscript; available in PMC: 2012 Jul 20.
Published in final edited form as: Pediatr Radiol. 2012 Jan 17;42(7):824–833. doi: 10.1007/s00247-011-2338-2

Table 3.

a Total US-CT agreement scores before and after use of US contrast agent at four escalating doses

Subject Pre-contrast Score Post-contrast Score % Change
Cohort 1: Dose Level = 0.175 mL/m2
1 62 67 8.1%
2 74 77 4.1%
3 68 67 −1.5%
Cohort 2: Dose Level = 0.200 mL/m2
b4 47 52 10.6%
5 67 70 4.5%
b6 59 62 5.1%
Cohort 3: Dose Level = 0.275 mL/m2
7 68 66 −2.9%
8 68 64 −5.9%
b9 60 61 1.7%
Cohort 4: Dose Level = 0.350 mL/m2
10 70 75 7.1%
11 68 68 0%
12 60 67 11.7%
a

Sum of individual parameter US-CT agreement scores for three reviewers for each subject.

b

The score does not include data for tumor appearance which could not be evaluated due to technical factors.